USAn vaalit Ylenannolla - Kooste - "Julius Kivi julkaisi koostevideon, joka dokumentoi globalistisen propagandamedian ”turpaan ottoa” Yleisradiossa, kun vaalitulokset Suomen NATO/DCA-isäntämaasta Yhdysvalloista menivät täydellisesti toisin kuin suomalaisille on kiihkeästi luuloteltu.
Kun luvut menivät täysin toisin kuin toivottiin, Kamala Harris oli selkeästi häviöllä alusta alkaen, totuutta ei vaan haluttu millään myöntää…" https://www.youtube.com/watch?v=BZHpAK8T6zA https://mvlehti.net/2024/11/07/paivan-video-kuinka-yle-havisi-vaalit-yhdysvalloissa/
Kun luvut menivät täysin toisin kuin toivottiin, Kamala Harris oli selkeästi häviöllä alusta alkaen, totuutta ei vaan haluttu millään myöntää…" https://www.youtube.com/watch?v=BZHpAK8T6zA https://mvlehti.net/2024/11/07/paivan-video-kuinka-yle-havisi-vaalit-yhdysvalloissa/
Benny Johnson:
• Donald Trump wins 312 Electoral Votes.
• Hey Libs, This is a landslide
• And it’s about to get much worse.
• National Voter ID is coming.
• Mass deportations of criminal aliens
• Along with new census maps greatly empowering red states
• The Obama Dynasty is officially over
• You failed
https://x.com/bennyjohnson/status/1854347577556164651
• Donald Trump wins 312 Electoral Votes.
• Hey Libs, This is a landslide
• And it’s about to get much worse.
• National Voter ID is coming.
• Mass deportations of criminal aliens
• Along with new census maps greatly empowering red states
• The Obama Dynasty is officially over
• You failed
https://x.com/bennyjohnson/status/1854347577556164651
Afghanistan Taliban govt hopes for 'new chapter' with Trump election win
RFK Jr kertoo MSNBC:lle, että hän aikoo tyhjentää kokonaisia osastoja FDA:sta.https://x.com/TheInsiderPaper/status/1854244266455019659
X (formerly Twitter)
Insider Paper (@TheInsiderPaper) on X
JUST IN - RFK Jr tells MSNBC that he intends to clear out entire departments of the FDA
Forwarded from Dot Connecting Anons (𝑀𝑒𝓁𝒾𝓈𝓈𝒶)
Over a year later, and now that RFK Jr is about to MAHA, we're circling back to— The FDA wants to pull common cold and flu medications from drugstore shelves after studies found the main ingredient was useless in treating the viruses.
The agency proposed on Thursday discontinuing the use of phenylephrine, an ingredient in common medications like Sudafed and Benadryl, in over-the-counter products because it 'is not effective' in treating or relieving virus symptoms such as nasal congestion.
The key ingredient in a wide variety of over-the-counter nasal decongestants has been thought to be ineffective for years and in March 2023, the FDA began reviewing the use of phenylephrine after a meta-analysis found it was no more effective than a placebo.
Dr Patrizia Cavazzoni, director of the FDA’s Center for Drug Evaluation and Research (CDER), said in the agency's notice: 'It is the FDA’s role to ensure that drugs are safe and effective.
'Based on our review of available data, and consistent with the advice of the advisory committee, we are taking this next step in the process to propose removing oral phenylephrine because it is not effective as a nasal decongestant.'
The proposed order only applies to the active ingredient phenylephrine, which is sold under brand-name products.
READ | XPOST
The agency proposed on Thursday discontinuing the use of phenylephrine, an ingredient in common medications like Sudafed and Benadryl, in over-the-counter products because it 'is not effective' in treating or relieving virus symptoms such as nasal congestion.
The key ingredient in a wide variety of over-the-counter nasal decongestants has been thought to be ineffective for years and in March 2023, the FDA began reviewing the use of phenylephrine after a meta-analysis found it was no more effective than a placebo.
Dr Patrizia Cavazzoni, director of the FDA’s Center for Drug Evaluation and Research (CDER), said in the agency's notice: 'It is the FDA’s role to ensure that drugs are safe and effective.
'Based on our review of available data, and consistent with the advice of the advisory committee, we are taking this next step in the process to propose removing oral phenylephrine because it is not effective as a nasal decongestant.'
The proposed order only applies to the active ingredient phenylephrine, which is sold under brand-name products.
READ | XPOST